GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (NAS:FBLG) » Definitions » Beginning Cash Position

FibroBiologics (FibroBiologics) Beginning Cash Position : $9.16 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics Beginning Cash Position?

FibroBiologics's Beginning Cash Position for the quarter that ended in Mar. 2024 was $9.16 Mil.

FibroBiologics's quarterly Beginning Cash Position declined from Sep. 2023 ($11.38 Mil) to Dec. 2023 ($10.77 Mil) and declined from Dec. 2023 ($10.77 Mil) to Mar. 2024 ($9.16 Mil).

FibroBiologics's annual Beginning Cash Position increased from Dec. 2021 ($-0.00 Mil) to Dec. 2022 ($0.41 Mil) and increased from Dec. 2022 ($0.41 Mil) to Dec. 2023 ($2.27 Mil).


FibroBiologics Beginning Cash Position Historical Data

The historical data trend for FibroBiologics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics Beginning Cash Position Chart

FibroBiologics Annual Data
Trend Dec21 Dec22 Dec23
Beginning Cash Position
- 0.41 2.27

FibroBiologics Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only 2.27 14.74 11.38 10.77 9.16

FibroBiologics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.


FibroBiologics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of FibroBiologics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


FibroBiologics (FibroBiologics) Business Description

Comparable Companies
Traded in Other Exchanges
Address
455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598
FibroBiologics Inc is an early-stage, cell therapy company. Its primary focus is the initiation and progression of preclinical studies and clinical-stage FDA trials related to fibroblast treatments for Degenerative Disc Disease, Multiple Sclerosis, Cancer, Wound Healing, and other diseases.

FibroBiologics (FibroBiologics) Headlines